Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 4.378
+0.028 (0.63%)
Aug 17, 2026, 3:26 PM GMT
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 46.54 million as of August 17, 2026. Its market cap has decreased by -20.92% in one year.
Market Cap
46.54M
Enterprise Value
60.30M
Revenue
36.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.38
ChartMarket Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 46.54M, a decrease of -72.59%. That is a compound annual growth rate of -11.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 46.54M | -55.50% |
| Dec 31, 2025 | 104.59M | 395.31% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 31.32B |
| Hikma Pharmaceuticals | 3.45B |
| HUTCHMED (China) | 1.61B |
| Allergy Therapeutics | 332.46M |
| Venture Life Group | 82.23M |
| ECO Animal Health Group | 68.44M |
| Provexis | 27.33M |
| Hellenic Dynamics | 1.32M |